1. Home
  2. NNNN vs HEQ Comparison

NNNN vs HEQ Comparison

Compare NNNN & HEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$3.81

Market Cap

163.7M

Sector

Health Care

ML Signal

HOLD

HEQ

John Hancock Hedged Equity & Income Fund of Beneficial Interest

HOLD

Current Price

$11.23

Market Cap

139.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
HEQ
Founded
2021
N/A
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
163.7M
139.0M
IPO Year
2023
2010

Fundamental Metrics

Financial Performance
Metric
NNNN
HEQ
Price
$3.81
$11.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 51.5K
22.4K
Earning Date
11-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$446.57
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$10.50
52 Week High
$44.73
$12.00

Technical Indicators

Market Signals
Indicator
NNNN
HEQ
Relative Strength Index (RSI) 31.81 46.95
Support Level $3.09 $10.88
Resistance Level $6.95 $11.63
Average True Range (ATR) 0.50 0.19
MACD 0.02 0.03
Stochastic Oscillator 28.99 51.42

Price Performance

Historical Comparison
NNNN
HEQ

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest

John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return, with a focus on current income and gains, and to include long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.

Share on Social Networks: